Public Shell Company for Acquisition (Nasdaq)

This listing offers a Nasdaq-listed public shell company for acquisition. It is an ideal opportunity for businesses looking to achieve public market status through a reverse merger or SPAC transaction. While the specific industry is not defined, there is a stated preference for companies within the bio-tech or medical device sectors. Interested parties are required to submit current audited financials and an executive summary or deck. The terms of the acquisition are negotiable.